New Frontiers in the Medical Therapy of Hepatocellular Carcinoma

Abstract Background: Hepatocellular carcinoma (HCC) is the most common primary liver tumor, and it rates fourth as a cause of cancer-related death. The presence of underlying liver disease and poor chemosensitivity pose major treatment challenges in the management of HCC. However, in the last few ye...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Chemotherapy (Basel) 2022-08, Vol.67 (3), p.164-172
Hauptverfasser:	Fulgenzi, Claudia Angela Maria, D’Alessio, Antonio, Talbot, Thomas, Gennari, Alessandra, Openshaw, Mark R., Demirtas, Coskun O., Cortellini, Alessio, Pinato, David J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors - therapeutic use Anticancer Section / Review Bevacizumab - therapeutic use Carcinoma, Hepatocellular - therapy Humans Immunotherapy - methods Liver Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!